| SC 13G/A | 2019-03-11 | EcoR1 Capital, LLC | IMMUNE DESIGN CORP. | - | - | EDGAR |
| SC 13D/A | 2019-02-28 | Versant Venture Capital III, L.P. | IMMUNE DESIGN CORP. | 2,195,251 | 4.6% | EDGAR |
| SC 13G/A | 2019-02-25 | BIOTECHNOLOGY VALUE FUND L P | IMMUNE DESIGN CORP. | - | 0.0% | EDGAR |
| SC 13D/A | 2019-02-19 | COLUMN GROUP L P | IMMUNE DESIGN CORP. | 3,161,942 | 6.6% | EDGAR |
| SC 13G/A | 2019-02-14 | BIOTECHNOLOGY VALUE FUND L P | IMMUNE DESIGN CORP. | 2,502,758 | 5.2% | EDGAR |
| SC 13G/A | 2019-02-14 | Bain Capital Public Equity Management, LLC | IMMUNE DESIGN CORP. | 892,061 | 1.8% | EDGAR |
| SC 13G/A | 2019-01-28 | FRANKLIN RESOURCES INC | IMMUNE DESIGN CORP. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2019-01-10 | EcoR1 Capital, LLC | IMMUNE DESIGN CORP. | 5,603,191 | 11.6% | EDGAR |
| SC 13G/A | 2018-10-17 | BIOTECHNOLOGY VALUE FUND L P | IMMUNE DESIGN CORP. | 2,411,295 | 5.0% | EDGAR |
| SC 13G/A | 2018-02-14 | Bain Capital Public Equity Management, LLC | Immune Design Corp. | 3,316,769 | 6.9% | EDGAR |
| SC 13G/A | 2018-02-14 | ProQuest Investments IV, L.P. | Immune Design Corp. | 1,236,394 | 2.6% | EDGAR |
| SC 13G/A | 2018-02-09 | BIOTECHNOLOGY VALUE FUND L P | Immune Design Corp. | 716,685 | 1.5% | EDGAR |
| SC 13G | 2018-02-09 | BIOTECHNOLOGY VALUE FUND L P | Immune Design Corp. | 1,936,934 | 4.0% | EDGAR |
| SC 13G/A | 2018-02-08 | VICTORY CAPITAL MANAGEMENT INC | Immune Design Corp. | 157,119 | 0.3% | EDGAR |
| SC 13G/A | 2018-02-07 | Topspin Fund L.P. | Immune Design Corp. | 5,526,514 | 11.5% | EDGAR |
| SC 13G | 2018-02-07 | FRANKLIN RESOURCES INC | Immune Design Corp. | 3,231,753 | 6.7% | EDGAR |
| SC 13G | 2017-11-06 | EcoR1 Capital, LLC | Immune Design Corp. | 3,562,600 | 7.4% | EDGAR |
| SC 13D/A | 2017-10-30 | COLUMN GROUP L P | Immune Design Corp. | 3,161,942 | 7.0% | EDGAR |
| SC 13G | 2017-10-06 | Bain Capital Public Equity Management, LLC | Immune Design Corp. | 1,299,013 | 5.1% | EDGAR |
| SC 13G/A | 2017-02-14 | FMR LLC | Immune Design Corp. | 443,453 | 1.7% | EDGAR |